23 August 2026
The pharmaceutical manufacturing crisis is worsening as procurement policies, rising costs, and imports threaten medicine supply.
22 August 2026
Pharmaceutical localisation talks target pricing reform, investment incentives, medicine security and stronger local manufacturing.
8 May 2026
Aspen Insulin approval marks a milestone for diabetes care in South Africa, ensuring supply security with locally made insulin.
22 August 2025
The recent R15.5 billion ARV tender sidelines Pharma Giants in South Africa, raising questions about local production support.